Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jain, S. K.
Right arrow Articles by Smith, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jain, S. K.
Right arrow Articles by Smith, T.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 9 1511-1516, Copyright © 1998 by American Diabetes Association

ARTICLES

Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients

SK Jain, KS Krueger, R McVie, JJ Jaramillo, M Palmer and T Smith
Department of Pediatrics, Louisiana State University Medical Center, Shreveport 71130, USA.

OBJECTIVE: To study the effect of vitamin E supplementation on platelet hyperaggregability in type 1 diabetic patients. RESEARCH DESIGN AND METHODS: Written informed consent according to the Institutional Review Board on Human Experimentation guidelines was obtained from diabetic patients (n = 29) and their age-matched normal siblings (n = 21) to participate in this study. Diabetic patients were supplemented with DL-alpha-tocopherol (vitamin E) capsule (orally, 100 IU/day) or placebo for 3 months in a double-blind clinical trial. Alternate diabetic patients were assigned to vitamin E or placebo during regular visits to the clinic. Fasting blood was collected from each diabetic patient before the start and after the vitamin E or placebo supplementation. Platelet aggregability was assessed by competitive enzyme-linked immunosorbent assay of the blood TxB2 (a stable thromboxane metabolite). Plasma vitamin E and MDA (malondialdehyde, a product of lipid peroxidation) was assessed by high-performance liquid chromatography. Data were analyzed statistically on 12 diabetic patients on vitamin E and 12 on placebo supplementation. RESULTS: Diabetic patients (n = 29) had 62% higher (P < 0.05) levels of TxB2 and 15% higher levels (P < 0.05) of MDA in comparison to normal subjects (n = 21). Plasma TxB2 levels had a significant correlation with MDA levels (r = 0.45, P < 0.02) but not with the HbA1 (r = -0.08), glucose (r = -0.13), duration of diabetes (r = -0.04), or age (r = 0.12) of diabetic patients. Vitamin E supplementation lowered MDA levels by 30% (P < 0.04), TxB2 levels by 51% (P < 0.03), and triglyceride levels by 22% (P < 0.04) in diabetic patients. There were no differences in these parameters before versus after placebo supplementation. CONCLUSIONS: The elevated blood level of TxB2 (hyperaggregability of platelets) is significantly related to the level of lipid peroxidation products (oxidative stress) in type 1 diabetic patients. Supplementation of modest doses of vitamin E (100 IU/day) significantly lowers blood TxB2 and lipid peroxidation products levels in type 1 diabetic patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
A. Michno, H. Bielarczyk, T. Pawelczyk, A. Jankowska-Kulawy, J. Klimaszewska, and A. Szutowicz
Alterations of Adenine Nucleotide Metabolism and Function of Blood Platelets in Patients With Diabetes
Diabetes, February 1, 2007; 56(2): 462 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Michno, A. Raszeja-Specht, A. Jankowska-Kulawy, T. Pawelczyk, and A. Szutowicz
Effect of L-Carnitine on Acetyl-CoA Content and Activity of Blood Platelets in Healthy and Diabetic Persons
Clin. Chem., September 1, 2005; 51(9): 1673 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Vericel, C. Januel, M. Carreras, P. Moulin, and M. Lagarde
Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status
Diabetes, April 1, 2004; 53(4): 1046 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A. Colwell and R. W. Nesto
The Platelet in Diabetes: Focus on prevention of ischemic events
Diabetes Care, July 1, 2003; 26(7): 2181 - 2188.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Yano, N. Kitagawa, E. C. Gabazza, K. Morioka, H. Urakawa, T. Tanaka, A. Katsuki, R. Araki-Sasaki, Y. Hori, K. Nakatani, et al.
Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Devaraj, A. V. C. Chan Jr., and I. Jialal
{alpha}-Tocopherol Supplementation Decreases Plasminogen Activator Inhibitor-1 and P-Selectin Levels in Type 2 Diabetic Patients
Diabetes Care, March 1, 2002; 25(3): 524 - 529.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
O.-G. Kwag, S.-O. Kim, J.-H. Choi, I.-K. Rhee, M.-S. Choi, and S.-J. Rhee
Vitamin E Improves Microsomal Phospholipase A2 Activity and the Arachidonic Acid Cascade in Kidney of Diabetic Rats
J. Nutr., April 1, 2001; 131(4): 1297 - 1301.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
W. Engelen, B. M. y Keenoy, J. Vertommen, and I. De Leeuw
Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes
Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1142 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Devaraj and I. Jialal
Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications : The Effect of {alpha}-Tocopherol Supplementation
Circulation, July 11, 2000; 102(2): 191 - 196.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.